BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 14, Issue 2
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (6158)
All Articles published online
The chart showing PDF series, HTML series.
Item 
Count 
PDF792
HTML5366
 Sum=6158
Jan 14, 2008 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Rector RS, Thyfault JP, Wei Y, Ibdah JA. Non-alcoholic fatty liver disease and the metabolic syndrome: An update. World J Gastroenterol 2008; 14(2): 185-192 [PMID: 18186553 DOI: 10.3748/wjg.14.185]
URL: https://www.wjgnet.com/1007-9327/full/v14/i2/185.htm
Number Citing Articles
1
Hyun-Yeol Nam, Sungmin Jun, Kyoungjune Pak, In Joo Kim. Concurrent Low Brain and High Liver Uptake on FDG PET Are Associated with Cardiovascular Risk Factors. Korean Journal of Radiology 2017; 18(2): 392 doi: 10.3348/kjr.2017.18.2.392
2
Yusuf Yilmaz, Engin Ulukaya, Ozen Oz Gul, Mahmut Arabul, Cuma Bulent Gul, Ozlen Atug, Arzu Yilmaztepe Oral, Sibel Aker, Enver Dolar. Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease. Clinical Biochemistry 2009; 42(9): 802 doi: 10.1016/j.clinbiochem.2009.02.003
3
Ryan D. Sheldon, M. Harold Laughlin, R. Scott Rector. Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats. Journal of Applied Physiology 2014; 116(9): 1156 doi: 10.1152/japplphysiol.01275.2013
4
Qianyi Wang, Fumiaki Imamura, Wenjie Ma, Molin Wang, Rozenn N. Lemaitre, Irena B. King, Xiaoling Song, Mary L. Biggs, Joseph A. Delaney, Kenneth J. Mukamal, Luc Djousse, David S. Siscovick, Dariush Mozaffarian. Circulating and Dietary Trans Fatty Acids and Incident Type 2 Diabetes in Older Adults: The Cardiovascular Health Study. Diabetes Care 2015; 38(6): 1099 doi: 10.2337/dc14-2101
5
Zheng-Tao Liu, Tian-Chi Chen, Xiao-Xiao Lu, Jun Cheng, Hai-Yang Xie, Lin Zhou, Shu-Sen Zheng. PNPLA3 I148M variant affects non-alcoholic fatty liver disease in liver transplant recipients. World Journal of Gastroenterology 2015; 21(34): 10054-10056 doi: 10.3748/wjg.v21.i34.10054
6
Vanessa DeClercq, Danielle Stringer, Ryan Hunt, Carla G. Taylor, Peter Zahradka. Metabolic Syndrome. 2011; : 73 doi: 10.1002/9780470910016.ch4
7
Soo Jin Yang, Jung Mook Choi, Seoung Wan Chae, Won Jun Kim, Se Eun Park, Eun Jung Rhee, Won Young Lee, Ki Won Oh, Sung Woo Park, Sun Woo Kim, Cheol-Young Park, Ian Lanza. Activation of Peroxisome Proliferator-Activated Receptor Gamma by Rosiglitazone Increases Sirt6 Expression and Ameliorates Hepatic Steatosis in Rats. PLoS ONE 2011; 6(2): e17057 doi: 10.1371/journal.pone.0017057
8
Lake Li, Jie Hai, Zhiqiang Li, Yongli Zhang, Hua Peng, Kun Li, Xiaogang Weng. Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease. Food and Chemical Toxicology 2014; 63: 166 doi: 10.1016/j.fct.2013.08.036
9
Scott R. Rector, Matthew E. Morris, Suzanne Ridenhour, Grace M. Meers, Fong-Fu Hsu, John Turk, Jamal A. Ibdah. Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect. Hepatology 2013; 57(6): 2213 doi: 10.1002/hep.26285
10
Li Wang, Yu Chen, Yun-chuan Sui, Xing-qi Tan, Zhi Zhou, Ning Li, Le-ping Xu. Metformin Attenuates Liver Fat Content: Finding from Schizophrenia Patients with Olanzapine-induced Weight Gain. Clinical Psychopharmacology and Neuroscience 2020; 18(1): 67 doi: 10.9758/cpn.2020.18.1.67
11
Yin-Yin Liao, Kuen-Cheh Yang, Ming-Ju Lee, Kuo-Chin Huang, Jin-De Chen, Chih-Kuang Yeh. Multifeature analysis of an ultrasound quantitative diagnostic index for classifying nonalcoholic fatty liver disease. Scientific Reports 2016; 6(1) doi: 10.1038/srep35083
12
Ming-Feng Xia, Hong-Mei Yan, Huan-Dong Lin, Hua Bian, Bai-Shen Pan, Xiu-Zhong Yao, Ruo-Kun Li, Meng-Su Zeng, Xin Gao. Elevation of liver enzymes within the normal limits and metabolic syndrome. Clinical and Experimental Pharmacology and Physiology 2011; 38(6): 373 doi: 10.1111/j.1440-1681.2011.05519.x
13
Antonia Martín-Castillo, Maria Teresa Castells, Gracia Adánez, Maria Teresa Sánchez Polo, Bartolomé García Pérez, Ignacio Ayala. Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens. Biomedicine & Pharmacotherapy 2010; 64(4): 275 doi: 10.1016/j.biopha.2009.06.003
14
Ji Cheol Bae, Won Young Lee, Kun Ho Yoon, Joong Yeol Park, Hyun Sik Son, Kyung Ah Han, Kwan Woo Lee, Jeong Taek Woo, Young Cheol Ju, Won Jae Lee, Yoon Young Cho, Moon-Kyu Lee. Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial. Diabetes Care 2015; 38(7): 1245 doi: 10.2337/dc14-2852
15
Benjamin J. Stewart, James R. Roede, Jonathan A. Doorn, Dennis R. Petersen. Lipid aldehyde-mediated cross-linking of apolipoprotein B-100 inhibits secretion from HepG2 cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2009; 1791(8): 772 doi: 10.1016/j.bbalip.2009.04.004
16
Yongyuan Zhang, Tao Zhang, Chengqi Zhang, Fang Tang, Nvjuan Zhong, Hongkai Li, Xinhong Song, Haiyan Lin, Yanxun Liu, Fuzhong Xue. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population. BMJ Open 2015; 5(9): e008204 doi: 10.1136/bmjopen-2015-008204
17
Daniel Ferraz de Campos Mazo, Vicência Mara Rodrigues de Lima, Jose Tadeu Stefano, Fabiola Rabelo, Joel Faintuch, Claudia Pinto de Oliveira. Gluco-lipidic indices in treated hypothyroidism associated with nonalcoholic fatty liver disease. Arquivos de Gastroenterologia 2011; 48(3): 186 doi: 10.1590/S0004-28032011000300006
18
Zuoquan Xie, Houkai Li, Ke Wang, Jingchao Lin, Qi Wang, Guoping Zhao, Wei Jia, Qinghua Zhang. Analysis of transcriptome and metabolome profiles alterations in fatty liver induced by high-fat diet in rat. Metabolism 2010; 59(4): 554 doi: 10.1016/j.metabol.2009.08.022
19
Jeong In Lee, Min Chul Kim, Byung Sub Moon, Young Seok Song, Eun Na Han, Hyo Sun Lee, Yoonjeong Son, Jihyun Kim, Eun Jin Han, Hye-Jeong Park, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee. The Relationship between 10-Year Cardiovascular Risk Calculated Using the Pooled Cohort Equation and the Severity of Non-Alcoholic Fatty Liver Disease. Endocrinology and Metabolism 2016; 31(1): 86 doi: 10.3803/EnM.2016.31.1.86
20
G. Huang, S. Bhasin, E. R. Tang, A. Aakil, S. W. Anderson, H. Jara, M. Davda, T. G. Travison, S. Basaria. Effect of Testosterone Administration on Liver Fat in Older Men With Mobility Limitation: Results From a Randomized Controlled Trial. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2013; 68(8): 954 doi: 10.1093/gerona/gls259
21
Tsui-Yen Chang, Jong-Dar Chen. Fatty Liver and Metabolic Syndrome in Nonabdominally Obese Taiwanese Adults. Asia Pacific Journal of Public Health 2012; 24(3): 472 doi: 10.1177/1010539511402191
22
Bojana Vidović, Srđan Milovanović, Aleksandra Stefanović, Jelena Kotur-Stevuljević, Marija Takić, Jasmina Debeljak-Martačić, Maja Pantović, Brižita Đorđević. Effects of Alpha-Lipoic Acid Supplementation on Plasma Adiponectin Levels and Some Metabolic Risk Factors in Patients with Schizophrenia. Journal of Medicinal Food 2017; 20(1): 79 doi: 10.1089/jmf.2016.0070
23
Fatima Ameer, Lisa Scandiuzzi, Shahida Hasnain, Hubert Kalbacher, Nousheen Zaidi. De novo lipogenesis in health and disease. Metabolism 2014; 63(7): 895 doi: 10.1016/j.metabol.2014.04.003
24
Dragana Savic, Leanne Hodson, Stefan Neubauer, Michael Pavlides. The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients 2020; 12(8): 2178 doi: 10.3390/nu12082178
25
Yoo Bin Seo, A Lum Han. Association of the Serum Uric Acid-to-Creatinine Ratio with Nonalcoholic Fatty Liver Disease Diagnosed by Computed Tomography. Metabolic Syndrome and Related Disorders 2021; 19(2): 70 doi: 10.1089/met.2020.0086
26
Ö. Başar, E. Akbal, S. Köklü, Y. Tuna, E. Koçak, N. Başar, D. Tok, H. Erbiş, M. Şenes. Increased H-FABP concentrations in nonalcoholic fatty liver disease. Herz 2013; 38(4): 417 doi: 10.1007/s00059-012-3714-x
27
Gustavo W. Fernandes, Barbara M. L. C. Bocco. Hepatic Mediators of Lipid Metabolism and Ketogenesis: Focus on Fatty Liver and Diabetes. Current Diabetes Reviews 2021; 17(7) doi: 10.2174/1573399816999201103141216
28
Alessandro P. Delitala, Giampiero Capobianco, Giuseppe Delitala, Pier Luigi Cherchi, Salvatore Dessole. Polycystic ovary syndrome, adipose tissue and metabolic syndrome. Archives of Gynecology and Obstetrics 2017; 296(3): 405 doi: 10.1007/s00404-017-4429-2
29
John P Thyfault, R Scott Rector. Linking aerobic fitness, nonalcoholic fatty liver disease and the metabolic syndrome. Expert Review of Endocrinology & Metabolism 2009; 4(4): 299 doi: 10.1586/eem.09.17
30
Lakhanawan Charoensuk, Phonpilas Thongpon, Chutima Sitthirach, Apisit Chaidee, Kitti Intuyod, Chawalit Pairojkul, Ei Htet Htet Khin, Chanakan Jantawong, Kanjana Thumanu, Porntip Pinlaor, Nuttanan Hongsrichan, Somchai Pinlaor. High-fat/high-fructose diet and Opisthorchis viverrini infection promote metabolic dysfunction-associated steatotic liver disease via inflammation, fibrogenesis, and metabolic dysfunction. Acta Tropica 2025; 261: 107491 doi: 10.1016/j.actatropica.2024.107491
31
Sammy Saab, Vignan Manne, Jose Nieto, Jeffrey B. Schwimmer, Naga P. Chalasani. Nonalcoholic Fatty Liver Disease in Latinos. Clinical Gastroenterology and Hepatology 2016; 14(1): 5 doi: 10.1016/j.cgh.2015.05.001
32
Shan Jiang, Rong Zhang, Huating Li, Qichen Fang, Feng Jiang, Xuhong Hou, Cheng Hu, Weiping Jia. The Single Nucleotide Polymorphism rs499765 Is Associated with Fibroblast Growth Factor 21 and Nonalcoholic Fatty Liver Disease in a Chinese Population with Normal Glucose Tolerance. Lifestyle Genomics 2014; 7(3): 121 doi: 10.1159/000367943
33
Elena Zhuravleva, Oliver Tschopp, Brian A. Hemmings. Signaling Pathways in Liver Diseases. 2010; : 243 doi: 10.1007/978-3-642-00150-5_16
34
James P. Luyendyk, Grace L. Guo. Steatosis DeLIVERs High-Sensitivity C-Reactive Protein. Arteriosclerosis, Thrombosis, and Vascular Biology 2011; 31(8): 1714 doi: 10.1161/ATVBAHA.111.230722
35
Adil Mardinoglu, Rasmus Agren, Caroline Kampf, Anna Asplund, Mathias Uhlen, Jens Nielsen. Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nature Communications 2014; 5(1) doi: 10.1038/ncomms4083
36
Shira Zelber-Sagi, Dorit Nitzan-Kaluski, Rebecca Goldsmith, Muriel Webb, Izabel Zvibel, Ilana Goldiner, Laurie Blendis, Zamir Halpern, Ran Oren. Role of leisure-time physical activity in nonalcoholic fatty liver disease: A population-based study. Hepatology 2008; 48(6): 1791 doi: 10.1002/hep.22525
37
Marcio H. Rodrigues, Anderson S. Bruno, Jorge Nahas-Neto, Maria Emilia S. Santos, Eliana A. P. Nahas. Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women. Gynecological Endocrinology 2014; 30(5): 325 doi: 10.3109/09513590.2013.875992
38
Yusuf Yilmaz, Engin Ulukaya, Ozlen Atug, Enver Dolar. Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance. European Journal of Gastroenterology & Hepatology 2009; 21(11): 1247 doi: 10.1097/MEG.0b013e32832b77ae
39
Chiara Valtolina, Joris H Robben, Monique E van Wolferen, Hedwig S Kruitwagen, Ronald J Corbee, Robert P Favier, Louis C Penning. Gene expressions of de novo hepatic lipogenesis in feline hepatic lipidosis. Journal of Feline Medicine and Surgery 2020; 22(6): 500 doi: 10.1177/1098612X19857853
40
Kiyohisa Kamimura, Shigeki Nagamachi, Hideyuki Wakamatsu, Ryutaro Higashi, Mikio Ogita, Shin-ichiro Ueno, Seigo Fujita, Yoshiro Umemura, Toshiro Fujimoto, Masayuki Nakajo. Associations between liver 18F fluoro-2-deoxy-d-glucose accumulation and various clinical parameters in a Japanese population: influence of the metabolic syndrome. Annals of Nuclear Medicine 2010; 24(3): 157 doi: 10.1007/s12149-009-0338-1
41
Simran Polce, Cameron Burke, Lucas França, Benjamin Kramer, Antonio Marcus de Andrade Paes, Maria Carrillo-Sepulveda. Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats. Nutrients 2018; 10(5): 531 doi: 10.3390/nu10050531
42
Sandra A. Chung, Frederick Dorey, Steven Mittelman, Vicente Gilsanz. Effect of gender on intra-abdominal fat in teenagers and young adults. Pediatric Radiology 2011; 41(4): 469 doi: 10.1007/s00247-010-1880-7
43
Isabelle Arruda Barbosa, Eloá Mangabeira Santos, Alanna Fernandes Paraíso, Pablo Vinicyus Ferreira Chagas, Luís Paulo Oliveira, João Marcus Oliveira Andrade, Lucyana Conceição Farias, Bruna Mara Aparecida de Carvalho, Alfredo Maurício Batista de Paula, André Luiz Sena Guimarães, Sérgio Henrique Sousa Santos. Liraglutide alters hepatic metabolism in high-fat fed obese mice: A bioinformatic prediction and functional analysis. Meta Gene 2019; 20: 100553 doi: 10.1016/j.mgene.2019.100553
44
Aileen L. Green, Ulas Bagci, Sarfaraz Hussein, Patrick V. Kelly, Razi Muzaffar, Brent A. Neuschwander-Tetri, Medhat M. Osman. Brown adipose tissue detected by PET/CT imaging is associated with less central obesity. Nuclear Medicine Communications 2017; 38(7): 629 doi: 10.1097/MNM.0000000000000691
45
Bashu Dev Pardhe, Ojashpi Singh Kapali, Jennifer Mathias, Anjeela Bhetwal, Jyotsna Shakya, Pranita Shrestha, Meenu Prajapati, Sajani Prajapati, Nabina Adhikari Khanal, Puspa Raj Khanal. Elevated liver transaminases and their association with metabolic syndrome in type 2 diabetic patients attending tertiary care hospital of Nepal. Clinical Lipidology 2018; 13(1): 4 doi: 10.1080/17584299.2018.1505313
46
Hyun-Woo Joo, Yi-Sun Song, In-Hwa Park, Guang-Yin Shen, Jin-Hee Seong, Na-Kyoung Shin, A-Hyeon Lee, Hyuck Kim, Kyung-Soo Kim. Granulocyte Colony Stimulating Factor Ameliorates Hepatic Steatosis Associated with Improvement of Autophagy in Diabetic Rats. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/2156829
47
E Ji, M Y Jung, J H Park, S Kim, C R Seo, K W Park, E K Lee, C H Yeom, S Lee. Inhibition of adipogenesis in 3T3-L1 cells and suppression of abdominal fat accumulation in high-fat diet-feeding C57BL/6J mice after downregulation of hyaluronic acid. International Journal of Obesity 2014; 38(8): 1035 doi: 10.1038/ijo.2013.202
48
Hussein F. Sakr, Abdelaziz M. Hussein, Elsayed A. Eid, Mahmoud AlKhateeb. Possible mechanisms underlying fatty liver in a rat model of male hypogonadism: A protective role for testosterone. Steroids 2018; 135: 21 doi: 10.1016/j.steroids.2018.04.004
49
Adnan Khan, Heather M. Ross, Natalia Salinas Parra, Sarah L. Chen, Kashyap Chauhan, Makala Wang, Brian Yan, John Magagna, Jake Beiriger, Yash Shah, Taha Shahzad, Dina Halegoua-DeMarzio. Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD). Livers 2022; 2(4): 264 doi: 10.3390/livers2040022
50
Sean W. P. Koppe, Marc Elias, Richard H. Moseley, Richard M. Green. Trans fat feeding results in higher serum alanine aminotransferase and increased insulin resistance compared with a standard murine high-fat diet. American Journal of Physiology-Gastrointestinal and Liver Physiology 2009; 297(2): G378 doi: 10.1152/ajpgi.90543.2008
51
Roberta M. Machado, José T. Stefano, Claudia P.M.S. Oliveira, Evandro S. Mello, Fabiana D. Ferreira, Valeria S. Nunes, Vicência M.R. de Lima, Eder C.R. Quintão, Sergio Catanozi, Edna R. Nakandakare, Ana Maria P. Lottenberg. Intake of trans Fatty Acids Causes Nonalcoholic Steatohepatitis and Reduces Adipose Tissue Fat Content. The Journal of Nutrition 2010; 140(6): 1127 doi: 10.3945/jn.109.117937
52
Emanuela Esposito, Michela Campolo, Marika Cordaro, Giovanna Casili, Salvatore Cuzzocrea. Autophagy Networks in Inflammation. 2016; : 365 doi: 10.1007/978-3-319-30079-5_17
53
Gabriel C. Oniscu, Stephen J. Wigmore. Increasing Donor Body Weight to Prevent Small‐for‐Size Syndrome in Living Donor Liver Transplantation. World Journal of Surgery 2010; 34(10): 2409 doi: 10.1007/s00268-010-0671-5
54
Kayoung Lee. Metabolic syndrome predicts the incidence of hepatic steatosis in Koreans. Obesity Research & Clinical Practice 2010; 4(3): e217 doi: 10.1016/j.orcp.2010.02.004
55
Bo Kong, James P. Luyendyk, Ossama Tawfik, Grace L. Guo. Farnesoid X Receptor Deficiency Induces Nonalcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Knockout Mice Fed a High-Fat Diet. The Journal of Pharmacology and Experimental Therapeutics 2009; 328(1): 116 doi: 10.1124/jpet.108.144600
56
Chihiro Ebihara, Megumi Aizawa-Abe, Mingming Zhao, Valentino Gumbilai, Ken Ebihara. Different sites of actions make different responses to thiazolidinediones between mouse and rat models of fatty liver. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-021-04036-7
57
Bernard Herbeth, Anastasia Samara, Coumba Ndiaye, Jean-Brice Marteau, Hind Berrahmoune, Gérard Siest, Sophie Visvikis-Siest. Metabolic syndrome-related composite factors over 5years in the STANISLAS Family Study: Genetic heritability and common environmental influences. Clinica Chimica Acta 2010; 411(11-12): 833 doi: 10.1016/j.cca.2010.02.070
58
Po-Hsin Chiang, Tsui-Yen Chang, Jong-Dar Chen. Synergistic effect of fatty liver and smoking on metabolic syndrome. World Journal of Gastroenterology 2009; 15(42): 5334-5339 doi: 10.3748/wjg.15.5334
59
Marten Heeringa, Ann Hastings, Shunji Yamazaki, Paul de Koning. Serum Biomarkers in Nonalcoholic Steatohepatitis: Value for Assessing Drug Effects?. Biomarkers in Medicine 2012; 6(6): 743 doi: 10.2217/bmm.12.87
60
Bahareh Sadat Yousefsani, Majid Dadmehr, Kobra Shirani, Amirhossein Jamshidi, Thozhukat Sathyapalan, Amirhossein Sahebkar. Natural Products and Human Diseases. Advances in Experimental Medicine and Biology 2021; 1328: 171 doi: 10.1007/978-3-030-73234-9_12
61
Michael D. Roberts, C. Brooks Mobley, Ryan G. Toedebush, Alexander J. Heese, Conan Zhu, Anna E. Krieger, Clayton L. Cruthirds, Christopher M. Lockwood, John C. Hofheins, Charles E. Wiedmeyer, Heather J. Leidy, Frank W. Booth, R. Scott Rector. Western diet-induced hepatic steatosis and alterations in the liver transcriptome in adult Brown-Norway rats. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0382-3
62
Samaneh Asgari, Fereidoun Azizi, Farzad Hadaegh. The Optimal Cut-Points of Alanine Aminotransferase for Screening Metabolic Syndrome in Iranian Adults. International Journal of Endocrinology and Metabolism 2025; 23(1) doi: 10.5812/ijem-151542
63
L. Gerber, M. Otgonsuren, A. Mishra, C. Escheik, A. Birerdinc, M. Stepanova, Z. M. Younossi. Non‐alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population‐based study. Alimentary Pharmacology & Therapeutics 2012; 36(8): 772 doi: 10.1111/apt.12038
64
Mohamed A. Ibrahim, Entesar F. Amin, Salwa A. Ibrahim, Walaa Y. Abdelzaher, Aly M. Abdelrahman. Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats. European Journal of Pharmacology 2014; 724: 204 doi: 10.1016/j.ejphar.2013.12.024
65
Yi-ming Ma, Rong-ya Tao, Qian Liu, Juan Li, Jin-ying Tian, Xiao-lin Zhang, Zhi-yan Xiao, Fei Ye. PTP1B inhibitor improves both insulin resistance and lipid abnormalities in vivo and in vitro. Molecular and Cellular Biochemistry 2011; 357(1-2): 65 doi: 10.1007/s11010-011-0876-4
66
Sechang Oh, Takashi Shida, Kazumasa Yamagishi, Kiyoji Tanaka, Rina So, Takehiko Tsujimoto, Junichi Shoda. Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: A retrospective study. Hepatology 2015; 61(4): 1205 doi: 10.1002/hep.27544
67
Peter Fraunberger, Elisabeth Gröne, Hermann-Josef Gröne, Heinz Drexel, Autar K. Walli. Ezetimibe reduces cholesterol content and NF-kappaB activation in liver but not in intestinal tissue in guinea pigs. Journal of Inflammation 2017; 14(1) doi: 10.1186/s12950-017-0150-y
68
Xudong Wu, Yunzhou Li, Kesong Peng, Huiping Zhou. HIV protease inhibitors in gut barrier dysfunction and liver injury. Current Opinion in Pharmacology 2014; 19: 61 doi: 10.1016/j.coph.2014.07.008
69
Arthur J McCULLOUGH. Epidemiology of the metabolic syndrome in the USA. Journal of Digestive Diseases 2011; 12(5): 333 doi: 10.1111/j.1751-2980.2010.00469.x
70
JENNIFER L. TRILK, ANDREW ORTAGLIA, STEVEN N. BLAIR, MATTEO BOTTAI, TIMOTHY S. CHURCH, RUSSELL R. PATE. Cardiorespiratory Fitness, Waist Circumference, and Alanine Aminotransferase in Youth. Medicine & Science in Sports & Exercise 2013; 45(4): 722 doi: 10.1249/MSS.0b013e31827aa875
71
Ying Han, Jun-Ping Shi, An-Lin Ma, Yun Xu, Xiao-Dong Ding, Jian-Gao Fan. Randomized, Vitamin E-Controlled Trial of Bicyclol Plus Metformin in Non-Alcoholic Fatty Liver Disease Patients with Impaired Fasting Glucose. Clinical Drug Investigation 2014; 34(1): 1 doi: 10.1007/s40261-013-0136-3
72
Olivia C. Eller, E. Matthew Morris, John P. Thyfault, Julie A. Christianson. Early life stress reduces voluntary exercise and its prevention of diet-induced obesity and metabolic dysfunction in mice.. Physiology & Behavior 2020; 223: 113000 doi: 10.1016/j.physbeh.2020.113000
73
Marcio Hipolito Rodrigues, Anderson Souza Bruno, Jorge Nahas-Neto, Valeria C. Sandrim, Ludmila G. Muniz, Eliana Aguiar Petri Nahas. Evaluation of Clinical and Inflammatory Markers of Nonalcoholic Fatty Liver Disease in Postmenopausal Women with Metabolic Syndrome. Metabolic Syndrome and Related Disorders 2014; 12(6): 330 doi: 10.1089/met.2013.0140
74
Takashi Miyata, Yuki Shinden, Shota Motoyama, Yuta Sannomiya, Hozumi Tamezawa, Taigo Nagayama, Hisashi Nishiki, Akifumi Hashimoto, Daisuke Kaida, Hideto Fujita, Nobuhiko Ueda, Hiroyuki Takamura. Non-Alcoholic Fatty Liver Disease May Be a Risk Factor for Liver Metastasis After Radical Surgery for Colorectal Cancer: A Retrospective Study. Journal of Gastrointestinal Cancer 2024; 55(2): 932 doi: 10.1007/s12029-024-01042-6
75
Qian Zhang, Hui-Mao Zhang, Wen-Qian Qi, Yong-Gui Zhang, Ping Zhao, Jian Jiao, Jiang-Bin Wang, Chun-Yu Zhang. 3.0T <sup>1</sup>H magnetic resonance spectroscopy for assessment of steatosis in patients with chronic hepatitis C. World Journal of Gastroenterology 2015; 21(21): 6736-6744 doi: 10.3748/wjg.v21.i21.6736
76
Marina Núñez. Drug-Induced Liver Disease. 2013; : 505 doi: 10.1016/B978-0-12-387817-5.00028-5
77
Shi Fuyan, Leng Jing, Cao Wenjun, Tan Zhijun, Meng Weijing, Wang Suzhen, Xu Yongyong. Fatty Liver Disease Index: A Simple Screening Tool to Facilitate Diagnosis of Nonalcoholic Fatty Liver Disease in the Chinese Population. Digestive Diseases and Sciences 2013; 58(11): 3326 doi: 10.1007/s10620-013-2774-y
78
J. Tordjman, M. Guerre-Millo, K. Clément. Adipose tissue inflammation and liver pathology in human obesity. Diabetes & Metabolism 2008; 34(6): 658 doi: 10.1016/S1262-3636(08)74601-9
79
Rubina Ghani, Shaista Emad, Samia Perwaiz Khan, Uzma Naseeb, Fahad Ahmed, Sehrish Zia. Liver Enzyme Correlated with C-Reactive Protein as a Biomarker of Metabolic Syndrome in Elderly Patients. Pakistan Journal of Health Sciences 2023; : 280 doi: 10.54393/pjhs.v4i05.364
80
Zehong Yang, Yuanyuan Yu, Nannan Sun, Limian Zhou, Dong Zhang, HaiXin Chen, Wei Miao, Weihang Gao, Canyang Zhang, Changhui Liu, Xiaoying Yang, Xiaojie Wu, Yong Gao. Ginsenosides Rc, as a novel SIRT6 activator, protects mice against high fat diet induced NAFLD. Journal of Ginseng Research 2023; 47(3): 376 doi: 10.1016/j.jgr.2020.07.005
81
Tao Zhang, Yongyuan Zhang, Chengqi Zhang, Fang Tang, Hongkai Li, Qian Zhang, Haiyan Lin, Shuo Wu, Yanxun Liu, Fuzhong Xue, Lars Kaderali. Prediction of Metabolic Syndrome by Non-Alcoholic Fatty Liver Disease in Northern Urban Han Chinese Population: A Prospective Cohort Study. PLoS ONE 2014; 9(5): e96651 doi: 10.1371/journal.pone.0096651
82
Kevan Josloff, Jacob Beiriger, Adnan Khan, Richard J. Gawel, Richard S. Kirby, Aaron D. Kendrick, Abhinav K. Rao, Roy X. Wang, Michelle M. Schafer, Margaret E. Pearce, Kashyap Chauhan, Yash B. Shah, Gregary D. Marhefka, Dina Halegoua-DeMarzio. Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease. Journal of Cardiovascular Development and Disease 2022; 9(12): 419 doi: 10.3390/jcdd9120419
83
Qiong Wang, Lei Jiang, Jue Wang, Shoufeng Li, Yue Yu, Jia You, Rong Zeng, Xiang Gao, Liangyou Rui, Wenjun Li, Yong Liu. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice #. Hepatology 2009; 49(4): 1166 doi: 10.1002/hep.22774
84
Yongzhong Wei, Suzanne E. Clark, John P. Thyfault, Grace M.E. Uptergrove, Wenhan Li, Adam T. Whaley-Connell, Carlos M. Ferrario, James R. Sowers, Jamal A. Ibdah. Oxidative Stress-Mediated Mitochondrial Dysfunction Contributes to Angiotensin II-Induced Nonalcoholic Fatty Liver Disease in Transgenic Ren2 Rats. The American Journal of Pathology 2009; 174(4): 1329 doi: 10.2353/ajpath.2009.080697
85
Wenwu Huang, Boyuan Shen, Xiumei Li, Tongcun Zhang, Xiang Zhou. Benefits of Combining Sonchus brachyotus DC. Extracts and Synbiotics in Alleviating Non-Alcoholic Fatty Liver Disease. Foods 2023; 12(18): 3393 doi: 10.3390/foods12183393
86
Luisella Vigna, Cristina Vassalle, Amedea Silvia Tirelli, Francesca Gori, Laura Tomaino, Laura Sabatino, Fabrizia Bamonti. Gender-Related Association Between Uric Acid, Homocysteine, γ-Glutamyltransferase, Inflammatory Biomarkers and Metabolic Syndrome in Subjects Affected by Obesity. Biomarkers in Medicine 2017; 11(10): 857 doi: 10.2217/bmm-2017-0072
87
Zhang# Qian, Zhang# Yonggui, Zhang Chunyu, Zhao Ping, Jiao Jian, Wang Jiangbin. Hydrogen 1 (1H) magnetic resonance spectroscopy (MRS) of 3.0T in assessment of steatosis to antiviral therapy for chronic hepatitis C. African Journal of Biotechnology 2014; 13(53): 4753 doi: 10.5897/AJB2014.13468
88
Lajos Szollár. Fatty liver and global cardiometabolic risk. Orvosi Hetilap 2010; 151(47): 1946 doi: 10.1556/oh.2010.29003
89
Gadi Lalazar, Ehud Zigmond, Sarah Weksler-Zangen, Ami Ben Ya'acov, Miriam Sklair Levy, Nilla Hemed, Itamar Raz, Yaron Ilan. Oral Administration of β-Glucosylceramide for the Treatment of Insulin Resistance and Nonalcoholic Steatohepatitis: Results of a Double-Blind, Placebo-Controlled Trial. Journal of Medicinal Food 2017; 20(5): 458 doi: 10.1089/jmf.2016.3753
90
Elisabete Martins, Ana Oliveira. NAFLD and cardiovascular disease. Porto Biomedical Journal 2018; 3(2): e2 doi: 10.1016/j.pbj.0000000000000002
91
Shailaja Rao, Mallesh Kurakula, Nagarjuna Mamidipalli, Papireddy Tiyyagura, Bhaumik Patel, Ravi Manne. Pharmacological Exploration of Phenolic Compound: Raspberry Ketone—Update 2020. Plants 2021; 10(7): 1323 doi: 10.3390/plants10071323
92
FANG LIU, CHAO WANG, LIJUN ZHANG, YUQIAO XU, LINA JANG, YU GU, XIANGMEI CAO, XIN ZHAO, JING YE, QING LI. Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein. International Journal of Molecular Medicine 2014; 33(1): 51 doi: 10.3892/ijmm.2013.1560
93
Gabriela S. F. Castro, João F. R. Cardoso, Helio Vannucchi, Sérgio Zucoloto, Alceu Afonso Jordão. Fructose and NAFLD: metabolic implications and models of induction in rats. Acta Cirurgica Brasileira 2011; 26(suppl 2): 45 doi: 10.1590/S0102-86502011000800009
94
Andrea Torres, Lilia G. Noriega, Claudia Delgadillo-Puga, Armando R. Tovar, Arturo Navarro-Ocaña. Caffeoylquinic Acid Derivatives of Purple Sweet Potato as Modulators of Mitochondrial Function in Mouse Primary Hepatocytes. Molecules 2021; 26(2): 319 doi: 10.3390/molecules26020319
95
Seokwon Lee, Younglae Jung, Youngtae Bae, Sung Pil Yun, Suk Kim, Hongjae Jo, Hyung-Il Seo. Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in Breast Cancer Patients. Tumori Journal 2017; 103(2): 187 doi: 10.5301/tj.5000536
96
Jessica Sacks, Anny Mulya, Ciaran E. Fealy, Hazel Huang, John D. Mosinski, Mangesh R. Pagadala, Hideharu Shimizu, Esam Batayyah, Philip R. Schauer, Stacy A. Brethauer, John P. Kirwan. Effect of Roux-en-Y gastric bypass on liver mitochondrial dynamics in a rat model of obesity. Physiological Reports 2018; 6(4): e13600 doi: 10.14814/phy2.13600
97
Yong Jiang, Ming Xie, Wenlei Fan, Jiajia Xue, Zhengkui Zhou, Jing Tang, Guohong Chen, Shuisheng Hou. Transcriptome Analysis Reveals Differential Expression of Genes Regulating Hepatic Triglyceride Metabolism in Pekin Ducks During Dietary Threonine Deficiency. Frontiers in Genetics 2019; 10 doi: 10.3389/fgene.2019.00710
98
M. Netzer, G. Millonig, M. Osl, B. Pfeifer, S. Praun, J. Villinger, W. Vogel, C. Baumgartner. A new ensemble-based algorithm for identifying breath gas marker candidates in liver disease using ion molecule reaction mass spectrometry. Bioinformatics 2009; 25(7): 941 doi: 10.1093/bioinformatics/btp093
99
Sarah J. Borengasser, R. Scott Rector, Grace M. Uptergrove, E. Matthew Morris, James W. Perfield, Frank W. Booth, Kevin L. Fritsche, Jamal A. Ibdah, John P. Thyfault. Exercise and Omega-3 Polyunsaturated Fatty Acid Supplementation for the Treatment of Hepatic Steatosis in Hyperphagic OLETF Rats. Journal of Nutrition and Metabolism 2012; 2012: 1 doi: 10.1155/2012/268680
100
Chiara Gelli, Mirko Tarocchi, Ludovico Abenavoli, Laura Di Renzo, Andrea Galli, Antonino De Lorenzo. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(17): 3150-3162 doi: 10.3748/wjg.v23.i17.3150
101
Mehrnoosh Zakerkish, Abolghasem Assarzadeh, Seyed Saeed Seyedian, Alireza Jahanshahi. Prevalence of Metabolic Syndrome and Related Factors in Patients with Non-alcoholic Fatty Liver. Jundishapur Journal of Chronic Disease Care 2021; 11(1) doi: 10.5812/jjcdc.114541
102
Negar Dinarvand, Bahman Cheraghian, Zahra Rahimi, Samaneh Salehipour Bavarsad, Amirhooshang Bavarsad, Narges Mohammadtaghvaei. Examining dyslipidaemia, metabolic syndrome and liver enzyme levels in patients with prediabetes and type 2 diabetes in population from Hoveyzeh cohort study: A case–control study in Iran. Endocrinology, Diabetes & Metabolism 2023; 6(2) doi: 10.1002/edm2.401
103
Maria Hernandez-Rodas, Rodrigo Valenzuela, Luis Videla. Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2015; 16(10): 25168 doi: 10.3390/ijms161025168
104
Bradley Carrier, Shin Wen, Sophia Zigouras, Richard W. Browne, Zhuyun Li, Mulchand S. Patel, David L. Williamson, Todd C. Rideout, Yanqiao Zhang. Alpha-Lipoic Acid Reduces LDL-Particle Number and PCSK9 Concentrations in High-Fat Fed Obese Zucker Rats. PLoS ONE 2014; 9(3): e90863 doi: 10.1371/journal.pone.0090863
105
Hisashi Shimohiro, Shin‐Ichi Taniguchi, Masahiko Koda, Chieko Sakai, Sadako Yamada. Association Between Serum Soluble Low‐Density Lipoprotein Receptor Levels and Metabolic Factors in Healthy Japanese Individuals. Journal of Clinical Laboratory Analysis 2015; 29(1): 52 doi: 10.1002/jcla.21727
106
Meiqi Fan, Young-Jin Choi, Yujiao Tang, Sung Mun Bae, Hyun Pil Yang, Eun-Kyung Kim. Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease. Nutrients 2019; 11(11): 2586 doi: 10.3390/nu11112586
107
Eman F. Khaleel, Ghada A. Abdel-Aleem. Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin signaling, and blocking ghrelin acylation. Archives of Physiology and Biochemistry 2019; 125(1): 64 doi: 10.1080/13813455.2018.1437638
108
Ahmad Haider, Louis J.G. Gooren, Pawin Padungtod, Farid Saad. Beneficial effects of 2 years of administration of parenteral testosterone undecanoate on the metabolic syndrome and on non-alcoholic liver steatosis and C-reactive protein. hmbci 2010; 1(1): 27 doi: 10.1515/HMBCI.2010.002
109
C-F Kuo, K-H Yu, S-F Luo, C-T Chiu, Y-S Ko, J-S Hwang, W-Y Tseng, H-C Chang, H-W Chen, L-C See. Gout and risk of non-alcoholic fatty liver disease. Scandinavian Journal of Rheumatology 2010; 39(6): 466 doi: 10.3109/03009741003742797
110
Joan Tordjman, Christine Poitou, Danielle Hugol, Jean-Luc Bouillot, Arnaud Basdevant, Pierre Bedossa, Michèle Guerre-Millo, Karine Clement. Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: Influence of glycemic status. Journal of Hepatology 2009; 51(2): 354 doi: 10.1016/j.jhep.2009.02.031
111
Fatoumata Niang, Chantal Benelli, Catherine Ribière, Martine Collinet, Nadia Mehebik-Mojaat, Graziella Penot, Claude Forest, Anne-Marie Jaubert. Leptin Induces Nitric Oxide-Mediated Inhibition of Lipolysis and Glyceroneogenesis in Rat White Adipose Tissue. The Journal of Nutrition 2011; 141(1): 4 doi: 10.3945/jn.110.125765
112
Rulong Chen, Zhengyu Zuo, Qi Li, Hualin Wang, Na Li, Hongyu Zhang, Xiaoli Yu, Zhiguo Liu. DHA substitution overcomes high-fat diet-induced disturbance in the circadian rhythm of lipid metabolism. Food & Function 2020; 11(4): 3621 doi: 10.1039/C9FO02606A
113
Jian Wang, Chi Zhang, Zhiguo Zhang, Qiang Chen, Xuemian Lu, Minglong Shao, Liangmiao Chen, Hong Yang, Fangfang Zhang, Peng Cheng, Yi Tan, Ki-Soo Kim, Ki Ho Kim, Bochu Wang, Young Heui Kim. BL153 Partially Prevents High-Fat Diet Induced Liver Damage Probably via Inhibition of Lipid Accumulation, Inflammation, and Oxidative Stress. Oxidative Medicine and Cellular Longevity 2014; 2014: 1 doi: 10.1155/2014/674690
114
Sachina SUZUKI, Chiharu NISHIJIMA, Yoko SATO, Keizo UMEGAKI, Masatsune MURATA, Tsuyoshi CHIBA. <i>Coleus forskohlii</i> Extract Attenuated the Beneficial Effect of Diet-Treatment on NASH in Mouse Model. Journal of Nutritional Science and Vitaminology 2020; 66(2): 191 doi: 10.3177/jnsv.66.191
115
Evan S. Siegelman. Radiology Secrets Plus. 2011; : 134 doi: 10.1016/B978-0-323-06794-2.00017-1
116
F.N. Almeida, C.L. Salgueiro-Paradigorria, S.M. Franzói-de-Moraes, R.T. Nachbar, P. Chimin, M.R.M. Natali. Aerobic physical training after weaning improves liver histological and metabolic characteristics of diet-induced obese rats. Science & Sports 2013; 28(2): e19 doi: 10.1016/j.scispo.2012.06.003
117
Xiaodan Li, Xiaoyan Yu, Dewei Sun, Jinwei Li, Yong Wang, Peirang Cao, Yuanfa Liu. Effects of Polar Compounds Generated from the Deep-Frying Process of Palm Oil on Lipid Metabolism and Glucose Tolerance in Kunming Mice. Journal of Agricultural and Food Chemistry 2017; 65(1): 208 doi: 10.1021/acs.jafc.6b04565
118
Nobuhiro Zaima, Yumiko Matsuyama, Mitsutoshi Setou. Principal Component Analysis of Direct Matrix-Assisted Laser Desorption/Ionization Mass Spectrometric Data Related to Metabolites of Fatty Liver. Journal of Oleo Science 2009; 58(5): 267 doi: 10.5650/jos.58.267
119
Ryan D. Sheldon, Jaume Padilla, Nathan T. Jenkins, M. Harold Laughlin, R. Scott Rector. Chronic NOS inhibition accelerates NAFLD progression in an obese rat model. American Journal of Physiology-Gastrointestinal and Liver Physiology 2015; 308(6): G540 doi: 10.1152/ajpgi.00247.2014
120
Guobing Liu, Yan Hu, Yanzhao Zhao, Haojun Yu, Pengcheng Hu, Hongcheng Shi. Variations of the liver standardized uptake value in relation to background blood metabolism. Medicine 2018; 97(19): e0699 doi: 10.1097/MD.0000000000010699
121
Brett R Loman, Diego Hernández-Saavedra, Ruopeng An, R Scott Rector. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Nutrition Reviews 2018; 76(11): 822 doi: 10.1093/nutrit/nuy031
122
Meir Mizrahi, Ami Ben Ya'acov, Tomer Adar, Miriam Levy Sklair, Svetlana Gaska, Yaron Ilan. Oral Administration ofHoodia parvifloraAlleviates Insulin Resistance and Nonalcoholic Steatohepatitis. Journal of Medicinal Food 2019; 22(12): 1189 doi: 10.1089/jmf.2019.0093
123
Yue Yang, Tho X. Pham, Casey J. Wegner, Bohkyung Kim, Chai Siah Ku, Young-Ki Park, Ji-Young Lee. Astaxanthin lowers plasma TAG concentrations and increases hepatic antioxidant gene expression in diet-induced obesity mice. British Journal of Nutrition 2014; 112(11): 1797 doi: 10.1017/S0007114514002554
124
Tahereh Ranjbar, Ali Akbar Nekooeian, Nader Tanideh, Omid Koohi‐Hosseinabadi, Seyed Jalil Masoumi, Sasan Amanat, Negar Azarpira, Ahmad Monabati. A comparison of the effects of Stevia extract and metformin on metabolic syndrome indices in rats fed with a high‐fat, high‐sucrose diet. Journal of Food Biochemistry 2020; 44(8) doi: 10.1111/jfbc.13242
125
Yilin Zhao, Shijun Li, Hui Liu. Estimating the survival advantage based on telomere length and serum biomarkers of aging. Journal of Translational Medicine 2017; 15(1) doi: 10.1186/s12967-017-1267-8
126
Raniru S Randunu, Khaled Alawaini, Lee-Anne Huber, Edward W Randell, Janet A Brunton, Robert F Bertolo. Feeding Parenteral Nutrition in the Neonatal Period Programs Dyslipidemia in Adulthood in Yucatan Miniature Pigs. The Journal of Nutrition 2024; 154(11): 3353 doi: 10.1016/j.tjnut.2024.08.031
127
R. Scott Rector, John P. Thyfault. Does physical inactivity cause nonalcoholic fatty liver disease?. Journal of Applied Physiology 2011; 111(6): 1828 doi: 10.1152/japplphysiol.00384.2011
128
Ying Wang, Jing Tong, Bing Chang, Bai-Fang Wang, Dai Zhang, Bing-Yuan Wang. Relationship of SREBP-2 rs2228314 G>C Polymorphism with Nonalcoholic Fatty Liver Disease in a Han Chinese Population. Genetic Testing and Molecular Biomarkers 2014; 18(9): 653 doi: 10.1089/gtmb.2014.0116
129
Belinda Gray, Frederik Steyn, Peter Stephen Wynford Davies, Luis Vitetta. Liver function parameters, cholesterol, and phospholipid α-linoleic acid are associated with adipokine levels in overweight and obese adults. Nutrition Research 2014; 34(5): 375 doi: 10.1016/j.nutres.2014.04.001
130
Klementina Fon Tacer, Damjana Rozman. Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation. Journal of Lipids 2011; 2011: 1 doi: 10.1155/2011/783976
131
Jinsoo Song, In-Jeoung Baek, Sujeong Park, Jinjoo Oh, Deokha Kim, Kyung Song, Mi Kyung Kim, Hye Won Lee, Byoung Kuk Jang, Eun-Jung Jin. Deficiency of peroxisomal NUDT7 stimulates de novo lipogenesis in hepatocytes. iScience 2022; 25(10): 105135 doi: 10.1016/j.isci.2022.105135
132
Kanthi B. Krishna, Maja Stefanovic-Racic, Nikolaos Dedousis, Ian Sipula, Robert M. O'Doherty. Similar degrees of obesity induced by diet or aging cause strikingly different immunologic and metabolic outcomes. Physiological Reports 2016; 4(6): e12708 doi: 10.14814/phy2.12708
133
Masatoshi Kondoh, Takashi Shimada, Kazutake Fukada, Mayuko Morita, Kazuhiro Katada, Yasuki Higashimura, Katsura Mizushima, Mariko Okamori, Yuji Naito, Toshikazu Yoshikawa. Beneficial effects of heat-treated Enterococcus faecalis FK-23 on high-fat diet-induced hepatic steatosis in mice. British Journal of Nutrition 2014; 112(6): 868 doi: 10.1017/S0007114514001792
134
Zuzana Papackova, Eliska Palenickova, Helena Dankova, Jana Zdychova, Vojtech Skop, Ludmila Kazdova, Monika Cahova. Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: the evidence for the involvement of alternatively activated macrophages. Nutrition & Metabolism 2012; 9(1) doi: 10.1186/1743-7075-9-22
135
Shan Jiang, Cheng Yan, Qi-chen Fang, Meng-le Shao, Yong-liang Zhang, Yang Liu, Yi-ping Deng, Bo Shan, Jing-qi Liu, Hua-ting Li, Liu Yang, Jian Zhou, Zhi Dai, Yong Liu, Wei-ping Jia. Fibroblast Growth Factor 21 Is Regulated by the IRE1α-XBP1 Branch of the Unfolded Protein Response and Counteracts Endoplasmic Reticulum Stress-induced Hepatic Steatosis. Journal of Biological Chemistry 2014; 289(43): 29751 doi: 10.1074/jbc.M114.565960
136
Yun-Huei Ko, Te-Chih Wong, Ying-Ying Hsu, Kuan-Liang Kuo, Shwu Huey Yang. The Correlation Between Body Fat, Visceral Fat, and Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Disorders 2017; 15(6): 304 doi: 10.1089/met.2017.0001
137
MELISSA A. LINDEN, JUSTIN A. FLETCHER, E. MATTHEW MORRIS, GRACE M. MEERS, M. HAROLD LAUGHLIN, FRANK W. BOOTH, JAMES R. SOWERS, JAMAL A. IBDAH, JOHN P. THYFAULT, R. SCOTT RECTOR. Treating NAFLD in OLETF Rats with Vigorous-Intensity Interval Exercise Training. Medicine & Science in Sports & Exercise 2015; 47(3): 556 doi: 10.1249/MSS.0000000000000430
138
Gordon A.A. Ferns, Majid Ghayour-Mobarhan. Metabolic syndrome in Iran: A review. Translational Metabolic Syndrome Research 2018; 1: 10 doi: 10.1016/j.tmsr.2018.04.001
139
Dae Yoon Kim, Seong Ho Park, Seung Soo Lee, Hye Jin Kim, So Yeon Kim, Min-Young Kim, Yedaun Lee, Tae Kyoung Kim, Korosh Khalili, Mi Hyun Bae, Joo Yeon Lee, Sung-Gyu Lee, Eun Sil Yu. Contrast-enhanced computed tomography for the diagnosis of fatty liver: prospective study with same-day biopsy used as the reference standard. European Radiology 2010; 20(2): 359 doi: 10.1007/s00330-009-1560-x
140
Suzanne M. de la Monte, Ming Tong. Brain metabolic dysfunction at the core of Alzheimer's disease. Biochemical Pharmacology 2014; 88(4): 548 doi: 10.1016/j.bcp.2013.12.012
141
Belinda D Jackson, Joseph S Doyle, Jennifer F Hoy, Stuart K Roberts, John Colman, Margaret E Hellard, Joseph J Sasadeusz, David M Iser. Non‐cirrhotic portal hypertension in HIV mono‐infected patients. Journal of Gastroenterology and Hepatology 2012; 27(9): 1512 doi: 10.1111/j.1440-1746.2012.07148.x
142
Manabu Kishina, Masahiko Koda, Jun Kato, Shiho Tokunaga, Tomomitsu Matono, Takaaki Sugihara, Masaru Ueki, Yoshikazu Murawaki. Therapeutic effects of the direct renin inhibitor, aliskiren, on non‐alcoholic steatohepatitis in fatty liver Shionogi ob/ob male mice. Hepatology Research 2014; 44(8): 888 doi: 10.1111/hepr.12186
143
So Hee Park, Jiyun Park, Hasung Kim, Jungkuk Lee, So Yoon Kwon, You-Bin Lee, Gyuri Kim, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim. The association of fatty liver index and metabolic syndrome with cardiovascular outcomes, liver-related mortality, and all-cause mortality: a nationwide cohort study. Internal and Emergency Medicine 2025; 20(1): 105 doi: 10.1007/s11739-024-03758-6
144
Juan P Arab, Roberto Candia, Rodrigo Zapata, Cristi&aacute;n Muñoz, Juan P Arancibia, Jaime Poniachik, Alejandro Soza, Francisco Fuster, Javier Brahm, Edgar Sanhueza, Jorge Contreras, M Carolina Cuellar, Marco Arrese, Arnoldo Riquelme. Management of nonalcoholic fatty liver disease: An evidence-based clinical practice review. World Journal of Gastroenterology 2014; 20(34): 12182-12201 doi: 10.3748/wjg.v20.i34.12182
145
Wenqian Fang, Zhiyong Deng, Feriel Benadjaoud, Chongzhe Yang, Guo-Ping Shi. Cathepsin B deficiency ameliorates liver lipid deposition, inflammatory cell infiltration, and fibrosis after diet-induced nonalcoholic steatohepatitis. Translational Research 2020; 222: 28 doi: 10.1016/j.trsl.2020.04.011
146
T. Vallim, A.M. Salter. Regulation of hepatic gene expression by saturated fatty acids. Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) 2010; 82(4-6): 211 doi: 10.1016/j.plefa.2010.02.016
147
Duane D. Mellor, Nenad Naumovski. Effect of cocoa in diabetes: the potential of the pancreas and liver as key target organs, more than an antioxidant effect?. International Journal of Food Science & Technology 2016; 51(4): 829 doi: 10.1111/ijfs.13075
148
Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 2009; 16(2): 189 doi: 10.1097/MED.0b013e328329fcc2
149
Haiyan Zhang, Wen-Jun Shen, Yihang Li, Alex Bittner, Stefanie Bittner, Juveria Tabassum, Yuan F. Cortez, Fredric B. Kraemer, Salman Azhar. Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats. Nutrition & Metabolism 2016; 13(1) doi: 10.1186/s12986-016-0121-y
150
James W. Perfield, Laura C. Ortinau, R. Taylor Pickering, Meghan L. Ruebel, Grace M. Meers, R. Scott Rector. Altered Hepatic Lipid Metabolism Contributes to Nonalcoholic Fatty Liver Disease in Leptin-Deficient Ob/Ob Mice. Journal of Obesity 2013; 2013: 1 doi: 10.1155/2013/296537
151
Monique Cristine de Oliveira, Rosana Torrezan, Cecília Edna Mareze da Costa, Célia Regina Ambiel, Rodrigo Polimeni Constantin, Emy Luiza Ishii-Iwamoto, Clairce Luzia Salgueiro-Pagadigorria. Changes in calcium fluxes in mitochondria, microsomes, and plasma membrane vesicles of livers from monosodium l-glutamate–obese rats. Metabolism 2011; 60(10): 1433 doi: 10.1016/j.metabol.2011.02.011
152
Vicente Gilsanz, Sandra A. Chung, Neil Kaplowitz. Differential effect of gender on hepatic fat. Pediatric Radiology 2011; 41(9): 1146 doi: 10.1007/s00247-011-2021-7
153
M Pallavi, MM Suchitra, P.V.L.N Srinivasa Rao. Role of adipokines in the pathogenesis of nonalcoholic fatty liver disease. Journal of Clinical and Scientific Research 2015; 4(1): 31 doi: 10.15380/2277-5706.JCSR.14.072
154
Jeffrey C. Sirota, Kim McFann, Giovanni Targher, Richard J. Johnson, Michel Chonchol, Diana I. Jalal. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism 2013; 62(3): 392 doi: 10.1016/j.metabol.2012.08.013
155
Santosh Kumar, Sreyoshi F. Alam, Paul K. Ganguly. Pathophysiology of Obesity-Induced Health Complications. 2020; : 181 doi: 10.1007/978-3-030-35358-2_11
156
Masahiko SOGA, Setsuko HASHIMOTO, Yoshio KISHIMOTO, Tsutomu HIRASAWA, Susumu MAKINO, Shuichiro INAGAKI. Insulin Resistance, Steatohepatitis, and Hepatocellular Carcinoma in a New Congenic Strain of Fatty Liver Shionogi (FLS) Mice with the Lepob Gene. Experimental Animals 2010; 59(4): 407 doi: 10.1538/expanim.59.407
157
Michał Kukla, Włodzimierz Mazur, Rafał J. Bułdak, Krystyna Żwirska-Korczala. Potential Role of Leptin, Adiponectin and Three Novel Adipokines—Visfatin, Chemerin and Vaspin—in Chronic Hepatitis. Molecular Medicine 2011; 17(11-12): 1397 doi: 10.2119/molmed.2010.00105
158
E. Matthew Morris, Justin A. Fletcher, John P. Thyfault, R. Scott Rector. The role of angiotensin II in nonalcoholic steatohepatitis. Molecular and Cellular Endocrinology 2013; 378(1-2): 29 doi: 10.1016/j.mce.2012.04.013
159
Mark M Smits, George N Ioannou, Edward J Boyko, Kristina M Utzschneider. Non‐alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups. Journal of Gastroenterology and Hepatology 2013; 28(4): 664 doi: 10.1111/jgh.12106
160
Erwin-Jan M. van Geenen, Mark M. Smits, Tim C.M.A. Schreuder, Donald L. van der Peet, Elisabeth Bloemena, Chris J.J. Mulder. Nonalcoholic Fatty Liver Disease Is Related to Nonalcoholic Fatty Pancreas Disease. Pancreas 2010; 39(8): 1185 doi: 10.1097/MPA.0b013e3181f6fce2
161
Daniela C. Kroy, Fabienne Schumacher, Pierluigi Ramadori, Maximilian Hatting, Ina Bergheim, Nikolaus Gassler, Mark V. Boekschoten, Michael Müller, Konrad L. Streetz, Christian Trautwein. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice. Journal of Hepatology 2014; 61(4): 883 doi: 10.1016/j.jhep.2014.05.019
162
Mile Janevski, Kiriakos N Antonas, Melanie J Sullivan-Gunn, Maree A McGlynn, Paul A Lewandowski. The effect of cocoa supplementation on hepatic steatosis, reactive oxygen species and LFABP in a rat model of NASH. Comparative Hepatology 2011; 10(1) doi: 10.1186/1476-5926-10-10
163
Geoffrey H. Tison, Michael J. Blaha, Khurram Nasir, Roger S. Blumenthal, Moyses Szklo, Jingzhong Ding, Matthew J. Budoff. Relation of Anthropometric Obesity and Computed Tomography Measured Nonalcoholic Fatty Liver Disease (from the Multiethnic Study of Atherosclerosis). The American Journal of Cardiology 2015; 116(4): 541 doi: 10.1016/j.amjcard.2015.05.012
164
Paloma Almeda-Valdés, Daniel Cuevas-Ramos, Carlos Alberto Aguilar-Salinas. Metabolic syndrome and non-alcoholic fatty liver disease. Annals of Hepatology 2009; 8: S18 doi: 10.1016/S1665-2681(19)31822-8
165
Tian-shu Zeng, Feng-min Liu, Jing Zhou, Shi-xiu Pan, Wen-fang Xia, Lu-lu Chen. Depletion of Kupffer cells attenuates systemic insulin resistance, inflammation and improves liver autophagy in high-fat diet fed mice. Endocrine Journal 2015; 62(7): 615 doi: 10.1507/endocrj.EJ15-0046
166
Gao Sun, Charles V. Jackson, Karen Zimmerman, Li-Kun Zhang, Courtney M. Finnearty, George E. Sandusky, Guodong Zhang, Richard G. Peterson, Yi-Xin (Jim) Wang. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0958-4
167
Lisa Kobos, Saeed Alqahtani, Li Xia, Vincent Coltellino, Riley Kishman, Daniel McIlrath, Carlos Perez-Torres, Jonathan Shannahan. Comparison of silver nanoparticle-induced inflammatory responses between healthy and metabolic syndrome mouse models. Journal of Toxicology and Environmental Health, Part A 2020; 83(7): 249 doi: 10.1080/15287394.2020.1748779
168
Murilo de Oliveira Lazarin, Emy Luiza Ishii-Iwamoto, Nair Seiko Yamamoto, Rodrigo Polimeni Constantin, Rosângela Fernandes Garcia, Cecília E. Mareze da Costa, Adriana de Souza Vitoriano, Monique Cristine de Oliveira, Clairce L. Salgueiro-Pagadigorria. Liver mitochondrial function and redox status in an experimental model of non-alcoholic fatty liver disease induced by monosodium l-glutamate in rats. Experimental and Molecular Pathology 2011; 91(3): 687 doi: 10.1016/j.yexmp.2011.07.003
169
Zanetta S. Lamar, Marina Núnez. Higher Risk of Severe Drug-Induced Liver Injury among Hispanic HIV-Infected Patients after Initiation of Highly Active Antiretroviral Therapy. Journal of the International Association of Physicians in AIDS Care 2011; 10(3): 183 doi: 10.1177/1545109711401411
170
Melissa A. Linden, Kristi T. Lopez, Justin A. Fletcher, E. Matthew Morris, Grace M. Meers, Sameer Siddique, M. Harold Laughlin, James R. Sowers, John P. Thyfault, Jamal A. Ibdah, R. Scott Rector. Combining metformin therapy with caloric restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in obese rats. Applied Physiology, Nutrition, and Metabolism 2015; 40(10): 1038 doi: 10.1139/apnm-2015-0236
171
Rômulo Pillon Barcelos, Luiz Fernando Freire Royes, Javier Gonzalez-Gallego, Guilherme Bresciani. Oxidative stress and inflammation: liver responses and adaptations to acute and regular exercise. Free Radical Research 2017; 51(2): 222 doi: 10.1080/10715762.2017.1291942
172
Sathish Natarajan, Jamal Ibdah. Role of 3-Hydroxy Fatty Acid-Induced Hepatic Lipotoxicity in Acute Fatty Liver of Pregnancy. International Journal of Molecular Sciences 2018; 19(1): 322 doi: 10.3390/ijms19010322
173
Kyong Yeun Jung, Sun Young Cho, Hyung Joon Kim, Suk Bae Kim, Il Han Song. Nonalcoholic Steatohepatitis Associated With Metabolic Syndrome. Journal of Clinical Gastroenterology 2014; 48(10): 883 doi: 10.1097/MCG.0000000000000065
174
Cornelia Weikert, Norbert Stefan, Matthias B. Schulze, Tobias Pischon, Klaus Berger, Hans-Georg Joost, Hans-Ulrich Häring, Heiner Boeing, Andreas Fritsche. Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke. Circulation 2008; 118(24): 2555 doi: 10.1161/CIRCULATIONAHA.108.814418
175
Anuradhani Kasturiratne, Sanjaya Weerasinghe, Anuradha S Dassanayake, Shaman Rajindrajith, Arjuna P de Silva, Norihiro Kato, A Rajitha Wickremasinghe, H Janaka de Silva. Influence of non‐alcoholic fatty liver disease on the development of diabetes mellitus. Journal of Gastroenterology and Hepatology 2013; 28(1): 142 doi: 10.1111/j.1440-1746.2012.07264.x
176
Marina Núñez. Clinical Syndromes and Consequences of Antiretroviral-Related Hepatotoxicity5, 1, 3. Hepatology 2010; 52(3): 1143 doi: 10.1002/hep.23716
177
Marcus Vinícius Nascimento‐Ferreira, Augusto César Ferreira De Moraes, Tara Rendo‐Urteaga, Elsie Costa de Oliveira Forkert, Tatiana Sadalla Collese, Gabriel Grizzo Cucato, Victor M. M. Reis, Francisco Leonardo Torres‐Leal, Luis A. Moreno, Heráclito Barbosa Carvalho. Cross‐sectional, school‐based study of 14–19 year olds showed that raised blood pressure was associated with obesity and abdominal obesity. Acta Paediatrica 2017; 106(3): 489 doi: 10.1111/apa.13699
178
Ana Maria Lottenberg, Milessa da Silva Afonso, Maria Silvia Ferrari Lavrador, Roberta Marcondes Machado, Edna Regina Nakandakare. The role of dietary fatty acids in the pathology of metabolic syndrome. The Journal of Nutritional Biochemistry 2012; 23(9): 1027 doi: 10.1016/j.jnutbio.2012.03.004
179
Johanna K. DiStefano. The Role of Choline, Soy Isoflavones, and Probiotics as Adjuvant Treatments in the Prevention and Management of NAFLD in Postmenopausal Women. Nutrients 2023; 15(12): 2670 doi: 10.3390/nu15122670
180
Ghada M. Safwat, Stefania Pisanò, Emanuela D'Amore, Giorgio Borioni, Mariarosaria Napolitano, Adel Amin Kamal, Paola Ballanti, Kathleen M. Botham, Elena Bravo. Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect?. Nutrition 2009; 25(11-12): 1157 doi: 10.1016/j.nut.2009.02.009
181
Stefanie Beck, Laurenz Jahn, Dominik Deniffel, Isabelle Riederer, Andreas Sauter, Marcus R. Makowski, Daniela Pfeiffer. Iodine Images in Dual-energy CT: Detection of Hepatic Steatosis by Quantitative Iodine Concentration Values. Journal of Digital Imaging 2022; 35(6): 1738 doi: 10.1007/s10278-022-00682-z
182
Corinna Brandsch, Tobias Schmidt, Diana Behn, Kristin Weiße, Andreas S Mueller, Gabriele I Stangl. Glutathione deficiency down-regulates hepatic lipogenesis in rats. Lipids in Health and Disease 2010; 9(1) doi: 10.1186/1476-511X-9-50
183
Grace Huang, Andrea Coviello. Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome. Current Opinion in Endocrinology, Diabetes & Obesity 2012; 19(6): 512 doi: 10.1097/MED.0b013e32835a000e
184
Sechang Oh, Kiyoji Tanaka, Takehiko Tsujimoto, Rina So, Takashi Shida, Junichi Shoda. Regular Exercise Coupled to Diet Regimen Accelerates Reduction of Hepatic Steatosis and Associated Pathological Conditions in Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Disorders 2014; 12(5): 290 doi: 10.1089/met.2013.0143
185
Yixiang Liu, Dan Wang, Di Zhang, Yechun Lv, Ying Wei, Wei Wu, Feng Zhou, Miaomiao Tang, Ting Mao, Mengmeng Li, Baoping Ji. Inhibitory Effect of Blueberry Polyphenolic Compounds on Oleic Acid-Induced Hepatic Steatosis in Vitro. Journal of Agricultural and Food Chemistry 2011; 59(22): 12254 doi: 10.1021/jf203136j
186
Aikaterini Margariti, Melanie Deutsch, Spilios Manolakopoulos, Dina Tiniakos, George V. Papatheodoridis. The Severity of Histologic Liver Lesions Is Independent of Body Mass Index in Patients With Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology 2013; 47(3): 280 doi: 10.1097/MCG.0b013e31826be328
187
Anastasia Samara, Bernard Herbeth, Roberte Aubert, Hind Berrahmoune, Frédéric Fumeron, Gérard Siest, Sophie Visvikis‐Siest. Sex‐dependent Associations of Leptin With Metabolic Syndrome–related Variables: The Stanislas Study. Obesity 2010; 18(1): 196 doi: 10.1038/oby.2009.156
188
Llorenç Caballería, Guillem Pera, Lluís Rodríguez, Maria Antònia Auladell, Jesús Bernad, Santiago Canut, Pere Torán. Metabolic syndrome and nonalcoholic fatty liver disease in a Spanish population. European Journal of Gastroenterology & Hepatology 2012; 24(9): 1007 doi: 10.1097/MEG.0b013e328355b87f
189
Ignacio Ayala, Antonia Martín Castillo, Gracia Adánez, Ana Fernández-Rufete, Bartolomé García Pérez, Maria T. Castells. Hyperlipidemic Chicken as a Model of Non-Alcoholic Steatohepatitis. Experimental Biology and Medicine 2009; 234(1): 10 doi: 10.3181/0807-RM-219
190
Hee Jae Lee, Soo Jin Yang. Effects of resveratrol on hepatic autophagy in high fat diet-induced obese mice. Journal of Nutrition and Health 2013; 46(4): 307 doi: 10.4163/jnh.2013.46.4.307
191
Waleed Al-hamoudi, Mohamed El-Sabbah, Safiyya Ali, Mansour Altuwaijri, Mohamed Bedewi, Mustafa Adam, Alwaleed Alhammad, Faisal Sanai, Khalid Alswat, Ayman Abdo. Epidemiological, clinical, and biochemical characteristics of Saudi patients with nonalcoholic fatty liver disease: a hospital-based study. Annals of Saudi Medicine 2012; 32(3): 288 doi: 10.5144/0256-4947.2012.288
192
Ingrid Arteaga, Isabel Buezo, Carmen Expósito, Guillem Pera, Lluís Rodríguez, Alba Alumà, M. Antònia Auladell, Pere Torán, Llorenç Caballería. Marcadores no invasivos de fibrosis en el diagnóstico del hígado graso no alcohólico. Gastroenterología y Hepatología 2014; 37(9): 503 doi: 10.1016/j.gastrohep.2014.03.009
193
Melissa A. Linden, Ryan D. Sheldon, Grace M. Meers, Laura C. Ortinau, E. Matthew Morris, Frank W. Booth, Jill A. Kanaley, Victoria J. Vieira‐Potter, James R. Sowers, Jamal A. Ibdah, John P. Thyfault, M. Harold Laughlin, R. Scott Rector. Aerobic exercise training in the treatment of non‐alcoholic fatty liver disease related fibrosis. The Journal of Physiology 2016; 594(18): 5271 doi: 10.1113/JP272235
194
KELLY A. BOWDEN DAVIES, VICTORIA S. SPRUNG, JULIETTE A. NORMAN, ANDREW THOMPSON, KATIE L. MITCHELL, JO A. HARROLD, GRAHAM FINLAYSON, CATHERINE GIBBONS, JOHN P. H. WILDING, GRAHAM J. KEMP, MARK HAMER, DANIEL J. CUTHBERTSON. Physical Activity and Sedentary Time: Association with Metabolic Health and Liver Fat. Medicine & Science in Sports & Exercise 2019; 51(6): 1169 doi: 10.1249/MSS.0000000000001901
195
Alejandro Aguayo-Orozco, Frederic Yves Bois, Søren Brunak, Olivier Taboureau. Analysis of Time-Series Gene Expression Data to Explore Mechanisms of Chemical-Induced Hepatic Steatosis Toxicity. Frontiers in Genetics 2018; 9 doi: 10.3389/fgene.2018.00396
196
Yunqin Ma, Mingliang Zhang, Haoyong Yu, Junxi Lu, Kenneth K.Y. Cheng, Jian Zhou, Haibing Chen, Weiping Jia. Activation of G0/G1 switch gene 2 by endoplasmic reticulum stress enhances hepatic steatosis. Metabolism 2019; 99: 32 doi: 10.1016/j.metabol.2019.06.015
197
Michelle Jones, Marina Núñez. HIV and hepatitis C co-infection. Current Opinion in HIV and AIDS 2011; 6(6): 546 doi: 10.1097/COH.0b013e32834bcbd9
198
Tsuyoshi Chiba, Keiko Noji, Shohei Shinozaki, Sachina Suzuki, Keizo Umegaki, Kentaro Shimokado. Diet-induced non-alcoholic fatty liver disease affects expression of major cytochrome P450 genes in a mouse model. Journal of Pharmacy and Pharmacology 2016; 68(12): 1567 doi: 10.1111/jphp.12646
199
S. J. Yang, H. B. IglayReger, H. C. Kadouh, P. F. Bodary. Inhibition of the chemokine (C–C motif) ligand 2/chemokine (C–C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy. Diabetologia 2009; 52(5): 972 doi: 10.1007/s00125-009-1309-8
200
Josilda Ferreira Cruz, Mário Augusto Ferreira Cruz, José Machado Neto, Demetrius Silva de Santana, Cristiane Costa da Cunha Oliveira, Sônia Oliveira Lima. Prevalence and sonographic changes compatible with fatty liver disease in patients referred for abdominal ultrasound examination in Aracaju, SE. Radiologia Brasileira 2016; 49(1): 1 doi: 10.1590/0100-3984.2014.0124
201
Anneloes E. Bohte, Jochem R. van Werven, Shandra Bipat, Jaap Stoker. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. European Radiology 2011; 21(1): 87 doi: 10.1007/s00330-010-1905-5
202
Suzanne M. de la Monte, Ming Tong. Metabolic Syndrome and Neurological Disorders. 2013; : 1 doi: 10.1002/9781118395318.ch1
203
Melissa A. Linden, Justin A. Fletcher, E. Matthew Morris, Grace M. Meers, Monica L. Kearney, Jacqueline M. Crissey, M. Harold Laughlin, Frank W. Booth, James R. Sowers, Jamal A. Ibdah, John P. Thyfault, R. Scott Rector. Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats. American Journal of Physiology-Endocrinology and Metabolism 2014; 306(3): E300 doi: 10.1152/ajpendo.00427.2013
204
Debrup Chakraborty, Jing Wang. Nonalcoholic fatty liver disease and colorectal cancer: Correlation and missing links. Life Sciences 2020; 262: 118507 doi: 10.1016/j.lfs.2020.118507
205
Adaelle Dantas Ribeiro, Eliara Orlando, Ilária Ferreira Chaves, João Marcos Costa de Siqueira, Juliana de Lima Tavares, Lázaro José Batista da Silva Mesquita, Luís Michel Silva Lima, Suévelem Patrícia Fedatto Granella, Cleber Queiroz Leite, Brian França dos Santos. Non-alcoholic hepatic steatosis and its relation with metabolic syndrome. Gastroenterology & Hepatology: Open Access 2023; 14(5): 161 doi: 10.15406/ghoa.2023.14.00562
206
Camelia Munteanu, Betty Schwartz. The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease. Antioxidants 2023; 12(4): 903 doi: 10.3390/antiox12040903
207
Tsuyoshi Chiba, Sachina Suzuki, Yoko Sato, Tatsuki Itoh, Keizo Umegaki, Giovanni Li Volti. Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice. PLOS ONE 2016; 11(10): e0164191 doi: 10.1371/journal.pone.0164191
208
Bradley S Henriksen, Mary E Curtis, Natasha Fillmore, Brandon R Cardon, David M Thomson, Chad R Hancock. The effects of chronic AMPK activation on hepatic triglyceride accumulation and glycerol 3-phosphate acyltransferase activity with high fat feeding. Diabetology & Metabolic Syndrome 2013; 5(1) doi: 10.1186/1758-5996-5-29
209
Yi-Sun Song, Cheng-Hu Fang, Byung-Im So, Jun-Young Park, Dae Won Jun, Kyung-Soo Kim. Therapeutic effects of granulocyte-colony stimulating factor on non-alcoholic hepatic steatosis in the rat. Annals of Hepatology 2013; 12(1): 115 doi: 10.1016/S1665-2681(19)31393-6
210
Azusa Kawashima, Naoto Uramaru, Toshiyasu Mikuma, Makoto Osabe, Toshiyuki Higuchi. Differential expression of Cytochrome P450 1A2 in simple fatty liver and steatohepatitis. Fundamental Toxicological Sciences 2023; 10(6): 265 doi: 10.2131/fts.10.265
211
John P. Thyfault, R. Scott Rector. Exercise Combats Hepatic Steatosis: Potential Mechanisms and Clinical Implications. Diabetes 2020; 69(4): 517 doi: 10.2337/dbi18-0043
212
Tong-shuo Zhang, Hua-lei Qin, Tong Wang, Hai-tao Li, Hai Li, Shi-hai Xia, Xiao-hui Xiang. Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic review. SpringerPlus 2015; 4(1) doi: 10.1186/s40064-015-1542-1
213
Tingting Shang, Liang Liu, Jia Zhou, Mingzhen Zhang, Qinling Hu, Min Fang, Yongning Wu, Ping Yao, Zhiyong Gong. Protective effects of various ratios of DHA/EPA supplementation on high-fat diet-induced liver damage in mice. Lipids in Health and Disease 2017; 16(1) doi: 10.1186/s12944-017-0461-2
214
Tolulope Eniola Omolekulo, Olugbenga Samuel Michael, Lawrence Aderemi Olatunji. Sodium acetate improves disrupted glucoregulation and hepatic triglyceride content in insulin-resistant female rats: involvement of adenosine deaminase and dipeptidyl peptidase-4 activities. Naunyn-Schmiedeberg's Archives of Pharmacology 2019; 392(1): 103 doi: 10.1007/s00210-018-1569-2
215
. Febyan, Norman Delvano Weky. Obesity and Non-Alcoholic Fatty Liver Disease: Pathophysiology and Management Focused. European Journal of Medical and Health Sciences 2021; 3(1): 6 doi: 10.24018/ejmed.2021.3.1.645
216
Hana Malínská, Olena Oliyarnyk, Miriam Hubová, Václav Zídek, Vladimír Landa, Miroslava Šimáková, Petr Mlejnek, Ludmila Kazdová, Theodore W. Kurtz, Michal Pravenec. Increased liver oxidative stress and altered PUFA metabolism precede development of non-alcoholic steatohepatitis in SREBP-1a transgenic spontaneously hypertensive rats with genetic predisposition to hepatic steatosis. Molecular and Cellular Biochemistry 2010; 335(1-2): 119 doi: 10.1007/s11010-009-0248-5
217
Jonas Valantinas, Daiva Asta Apanaviciene, Ligita Maroziene, Audrius Sveikata. The prevalence of metabolic risk factors among outpatients with diagnosed nonalcoholic fatty liver disease in Lithuania. Medical Science Monitor 2012; 18(5): PH57 doi: 10.12659/MSM.882722
218
H&uuml;seyin Saadettin Uslusoy, Selim Giray Nak, Macit G&uuml;lten, Zeynep Bıyıklı. Liver histology according to the presence of metabolic syndrome in nonalcoholic fatty liver disease cases. World Journal of Gastroenterology 2009; 15(9): 1093-1098 doi: 10.3748/wjg.15.1093
219
T. T. Nyakudya, E. Mukwevho, P. Nkomozepi, K. H. Erlwanger. Neonatal intake of oleanolic acid attenuates the subsequent development of high fructose diet-induced non-alcoholic fatty liver disease in rats. Journal of Developmental Origins of Health and Disease 2018; 9(5): 500 doi: 10.1017/S2040174418000259
220
Ren-ying Xu, Yan-ping Wan, Qi-yu Fang, Wei Lu, Wei Cai. Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model. Journal of Clinical Biochemistry and Nutrition 2011; 50(1): 72 doi: 10.3164/jcbn.11-38
221
Ana Lúcia Farias de Azevedo Salgado, Luciana de Carvalho, Ana Claudia Oliveira, Virgínia Nascimento dos Santos, Jose Gilberto Vieira, Edison Roberto Parise. Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals. Arquivos de Gastroenterologia 2010; 47(2): 165 doi: 10.1590/S0004-28032010000200009
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345